Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux

被引：8

作者：

Bordes, J.

Asencio, Y.

Kenane, N.

Fesselet, J.

Meaudre, E.

Goutorbe, P.

机构：

来源：

BRITISH JOURNAL OF ANAESTHESIA | 2008年 / 101卷 / 04期

关键词：

D O I：

10.1093/bja/aen255

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

收藏

页码：575 / 576

页数：2

相关论文

共 5 条

[1] Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers [J].

Bijsterveld, NR ;

Moons, AH ;

Boekholdt, SM ;

van Aken, BE ;

Fennema, H ;

Peters, RJG ;

Meijers, JCM ;

Büller, HR ;

Levi, M .

CIRCULATION, 2002, 106 (20) :2550-2554

[2]

Huvers F, 2005, NETH J MED, V63, P184

[3] Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux [J].

Lisman, T ;

Bijsterveld, NR ;

Adelmeijer, J ;

Meijers, JCM ;

Levi, M ;

Nieuwenhuis, HK ;

De Groot, PG .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (11) :2368-2373

[4] Recombinant activated factor VII for acute intracerebral hemorrhage [J].

Mayer, SA ;

Brun, NC ;

Begtrup, K ;

Broderick, J ;

Davis, S ;

Diringer, MN ;

Skolnick, BE ;

Steiner, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :777-785

[5] Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage [J].

Mayer, SA ;

Brun, NC ;

Broderick, J ;

Davis, S ;

Diringer, MN ;

Skolnick, BE ;

Steiner, T .

STROKE, 2005, 36 (01) :74-79